Technical Analysis for BXN - Bioxyne Ltd
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| New Uptrend | Bullish | -7.14% | |
| Narrow Range Bar | Range Contraction | -7.14% | |
| Stochastic Reached Overbought | Strength | -7.14% | |
| Wide Bands | Range Expansion | -7.14% | |
| Overbought Stochastic | Strength | -7.14% | |
| MACD Bullish Centerline Cross | Bullish | -7.14% |
| Alert | Time |
|---|---|
| Reversed from Up | 1 day ago |
| Rose Above Upper Bollinger Band | 1 day ago |
| Up 1 ATR | 1 day ago |
| Up 5% | 1 day ago |
| Up 2% | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Bioxyne Limited is an Australia-based bio-technology company engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The Company has an agreement to manufacture, market, supply and distribute its probiotic strain for over the counter dietary supplement products. Its segments include Probiotics and Other. It focuses on immune health and immunotherapeutic products. The Company's focus is on its probiotic business and product Lactobacillus fermentum PCC. The Company holds an interest in Mariposa Health Limited, a pharmaceutical development company with a focus on Congestive and Obstructive Pulmonary Disease (COPD).
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Disease Medical Specialties Therapeutic Product Therapeutic Products Bacteria Bacteriology Microbiology Over The Counter Dietary Supplement Copd Dietary Supplements Pharmaceutical Development Probiotic Bio Technology Digestive System Immunotherapeutic Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Disease Medical Specialties Therapeutic Product Therapeutic Products Bacteria Bacteriology Microbiology Over The Counter Dietary Supplement Copd Dietary Supplements Pharmaceutical Development Probiotic Bio Technology Digestive System Immunotherapeutic Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.021 |
| 52 Week Low | 0.004 |
| Average Volume | 1,476,270 |
| 200-Day Moving Average | 0.010 |
| 50-Day Moving Average | 0.012 |
| 20-Day Moving Average | 0.012 |
| 10-Day Moving Average | 0.013 |
| Average True Range | 0.001 |
| RSI (14) | 50.00 |
| ADX | 25.77 |
| +DI | 39.552 |
| -DI | 23.134 |
| Chandelier Exit (Long, 3 ATRs) | 0.011 |
| Chandelier Exit (Short, 3 ATRs) | 0.014 |
| Upper Bollinger Bands | 0.014 |
| Lower Bollinger Band | 0.011 |
| Percent B (%b) | 0.67 |
| BandWidth | 29.032 |
| MACD Line | 0.000 |
| MACD Signal Line | 0.000 |
| MACD Histogram | 0.0002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.015 | ||||
| Resistance 3 (R3) | 0.015 | 0.014 | 0.014 | ||
| Resistance 2 (R2) | 0.014 | 0.014 | 0.014 | 0.014 | |
| Resistance 1 (R1) | 0.014 | 0.014 | 0.014 | 0.014 | 0.014 |
| Pivot Point | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 |
| Support 1 (S1) | 0.013 | 0.013 | 0.013 | 0.013 | 0.012 |
| Support 2 (S2) | 0.012 | 0.013 | 0.012 | 0.012 | |
| Support 3 (S3) | 0.012 | 0.012 | 0.012 | ||
| Support 4 (S4) | 0.012 |
